Holen Sie sich die Stockscreener-App
2.04
2.39%
-0.05
Finanzdaten der Alzamend Neuro Inc-Aktie (ALZN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
137.08%
2.7002
|
1.1389 | 1.0374 | 1.3581 | 0.9624 |
| Interest Income/Expense |
387.82%
0.00248
|
0.000509 | 0.00202 | 0.0035 | 0.012 |
| Operating Income/Loss |
137.08%
-2.7002
|
-1.1389 | -1.0374 | -1.3581 | -0.9624 |
| Nonoperating Income/Loss |
387.82%
-0.00248
|
-0.000509 | -0.00202 | -0.0035 | -0.012 |
| Income/Loss From Continuing Operations Before Tax |
336.96%
2.70
|
-1.1394 | -1.0394 | -1.3616 | 1.00 |
| Income/Loss From Continuing Operations After Tax |
336.96%
2.70
|
-1.1394 | -1.0394 | -1.3616 | 1.00 |
|
Net Income/Loss
|
65.72%
2.70
|
7.8754 | -1.0394 | -1.3616 | 1.00 |
| Preferred Stock Dividends And Other Adjustments |
100.00%
-
|
0.5902 | - | - | - |
| Attributable To Noncontrolling Interest |
40.07%
5.4027
|
9.0149 | - | 0.0537 | 1.9744 |
| Basic Average Shares |
174.55%
2.106
|
-2.825 | 5.5178 | 3.5317 | 0.7778 |
| Diluted Average Shares |
174.55%
2.106
|
-2.825 | 5.5178 | 3.5317 | 0.7778 |
| Basic Earnings Per Share |
87.56%
-1.28
|
-10.29 | -0.19 | -0.40 | -1.25 |
| Diluted Earnings Per Share |
87.56%
-1.28
|
-10.29 | -0.19 | -0.40 | -1.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
100.00%
-
|
0.5902 | - | - | - |
0.18%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):